Work

S1452 Guselkumab Maintenance Dose Regimens in Patients With High Disease Activity and Severity: Subgroup Analysis of Participants With Moderately to Severely Active Crohn’s Disease in the GALAXI Phase 3 Studies

Year: 2025

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001133268.32992.d0

Authors: Anita Afzali, Tadakazu Hisamatsu, David T. Rubin, Nat A. Terry, Rian Van Rampelbergh, Jacqueline Yee, Kitty Yeun Yi Wan, Zijiang Yang, Walter Reinisch, Bruce E. Sands, Silvio Danese, Remo Panaccione

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417163467

Cites:

Cited by: 1

Related to: